IE38219L - Substituted 2-hydrazonomethyl-3-hydroxy-4-aza-2, 4-¹pentadiene nitriles - Google Patents

Substituted 2-hydrazonomethyl-3-hydroxy-4-aza-2, 4-¹pentadiene nitriles

Info

Publication number
IE38219L
IE38219L IE158473A IE158473A IE38219L IE 38219 L IE38219 L IE 38219L IE 158473 A IE158473 A IE 158473A IE 158473 A IE158473 A IE 158473A IE 38219 L IE38219 L IE 38219L
Authority
IE
Ireland
Prior art keywords
alkyl
hydrogen
group
replaced
alkenyl
Prior art date
Application number
IE158473A
Other versions
IE38219B1 (en
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of IE38219L publication Critical patent/IE38219L/en
Publication of IE38219B1 publication Critical patent/IE38219B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1427189 3 - Hydroxy - 2 - hydrazoxomethyl- 4-aza-2,4-pentadienenitriles BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 5 Sept 1973 [8 Sept 1972 (2)] 41667/73 Heading C2C Novel compounds in which A and B are hydrogen, hydroxy, C 1-7 alkoxy, NR<SP>8</SP>R<SP>9</SP> or NR<SP>8</SP>-C(=O)R<SP>9</SP> (in which R<SP>8</SP> and R‹ are hydrogen, C 1-7 alkyl, C 2-7 alkenyl or C 2-7 alkynyl group in which a methylene group may be replaced by oxygen, C 3-6 cycloalkyl or R<SP>8</SP> and R<SP>9</SP> together represent C 2-5 alkylene in which one or more methylene groups can be replaced by O, S or NR<SP>7</SP>) R<SP>3</SP> is (in which R<SP>4</SP> is hydrogen, a C 1-14 alkyl, C 2-7 alkenyl or C 2-7 alkynyl group in which an alkyl group may be optionally substituted by an NR<SP>5</SP>R<SP>6</SP> group and in which a methylene group may be replaced by oxygen, C 3-6 cycloalkyl optionally substituted by an NR<SP>5</SP>R<SP>6</SP> group, a phenyl or pheny-C 1-6 alkyl group (optionally substituted by C 1-7 alkyl, C 1-7 alkoxy, C 1-7 alkylthio, C 2-5 alkoxycarbonyl, halogen, trifluoromethyl, nitro and/or cyano) R<SP>5</SP> and R<SP>6</SP> are hydrogen, a C 1-6 alkyl C 2-7 alkenyl or C 2-7 alkynyl group in which a methylene group may be replaced by oxygen, C 3-6 cycloalkyl or R<SP>5</SP> and R<SP>6</SP> together represent C 2-5 alkylene in which one or more methylene groups may be replaced by O, S or NR<SP>7</SP>, X is O, S or NR<SP>7</SP> and Y is O, S or NH) and R<SP>7</SP> is hydrogen or C 1-7 alkyl, and their tautomers and salts are prepared by reaction of a compound II or III or their tautomers in which R<SP>10</SP> is OR<SP>11</SP>, SR<SP>11</SP> or NR<SP>5</SP>R<SP>6</SP> (in which R<SP>11</SP> is alkyl, phenyl or phenylalkyl) with the proviso that in Formula III neither A nor B is alkoxy with a compound R 3 -NH-NH 2 . Compounds I prepared are those in which (i) A is hydrogen and B is hydroxyl, dimethylamino, pyrrolidino or piperidino or (ii) A is hydroxyl and B is acetylamino and R<SP>3</SP> is -COR<SP>4</SP>, -COOR<SP>4</SP>, -CONR<SP>5</SP>R<SP>6</SP> C(=NH)NR<SP>5</SP>R<SP>6</SP> or CSNH 2 (in which R<SP>4</SP> is as above and R<SP>5</SP> and R<SP>6</SP> are hydrogen methyl or phenyl). Compounds I are useful in the treatment of gout, cardiac insufficiency and arrhythmia and form with a suitable vehicle a pharmaceutical composition which may be administered orally or parenterally. [GB1427189A]
IE158473A 1972-09-08 1973-09-06 Substituted 2-hydrazonomethyl 3-hydroxy 4-aza 2,4-pentadienenitriles a method for producing them and medicaments containing them IE38219B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU66039 1972-09-08
LU66038 1972-09-08

Publications (2)

Publication Number Publication Date
IE38219L true IE38219L (en) 1974-03-08
IE38219B1 IE38219B1 (en) 1978-01-18

Family

ID=26640115

Family Applications (1)

Application Number Title Priority Date Filing Date
IE158473A IE38219B1 (en) 1972-09-08 1973-09-06 Substituted 2-hydrazonomethyl 3-hydroxy 4-aza 2,4-pentadienenitriles a method for producing them and medicaments containing them

Country Status (9)

Country Link
JP (1) JPS4966632A (en)
CA (1) CA1020947A (en)
CH (1) CH599131A5 (en)
DE (1) DE2344738A1 (en)
FR (1) FR2198748B1 (en)
GB (1) GB1427189A (en)
IE (1) IE38219B1 (en)
NL (1) NL7312333A (en)
SE (1) SE7611589A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024038A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility

Also Published As

Publication number Publication date
JPS4966632A (en) 1974-06-27
FR2198748B1 (en) 1977-07-15
FR2198748A1 (en) 1974-04-05
GB1427189A (en) 1976-03-10
CH599131A5 (en) 1978-05-12
DE2344738A1 (en) 1974-04-04
CA1020947A (en) 1977-11-15
IE38219B1 (en) 1978-01-18
SE7611589A (en) 1976-10-19
NL7312333A (en) 1974-03-12

Similar Documents

Publication Publication Date Title
IE45256L (en) Quinazolone derivatives
ES8500242A1 (en) Imidazole derivatives, their preparation and medicines containing these compounds.
GB1265165A (en)
GB1116692A (en) A method for producing sydnonimine derivatives
ES8403910A1 (en) 3.6-dianhydro-hexite nitrates, processes for their preparation and pharmaceutical compositions.
ATE15048T1 (en) 4&#39;&#39;-EPI ERYTHROMYCIN A AND ITS DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS.
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
IE38219L (en) Substituted 2-hydrazonomethyl-3-hydroxy-4-aza-2, 4-¹pentadiene nitriles
ES480113A1 (en) Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
GB1417029A (en) Quinazoline-derived amines
GB1342828A (en) Pyrimidinyl-piperazines and processes for their preparation
ES441616A1 (en) Pharmacologically active anilinobenzothiazoles
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
DK535384A (en) 1,3-DIOXAN-4-YL-ALKENIC AND ALKANIC ACIDS, PROCEDURES FOR THE PREPARATION OF IT AND THEIR CONTENTS
GB1417104A (en) Imidazo 1,2-a- azacycloalkanes
GB1394791A (en) Diphenylalkyllactamimide derivatives
GB1203430A (en) Heterocyclic spiro compounds
GB1324676A (en) Derivatives of 1,7,7-trimethyl-2-norbornane-2-spiro-1,3-dioxolane their process of preparation and their therapeutic application
IE45096L (en) Thiadiazole derivatives
JPS55111419A (en) Antitumorigenic agent
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
GB1427849A (en) Substituted 3-chloro-2-hydrazonomethyl-4-aza-2,4-pentadiene nitriles, a method for producing them and medicaments containing them
GB1431617A (en) Benzopyrano- and benzothiopyranoindazole n-oxides
IE43978L (en) Pharmaceutical composition; 1,3-dialkyl-7-oxoalkylxanthines